Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Novel Therapeutic Target in Leukemia Stem Cells |
Cincinnati Children's Hospital Medical Center / James Mulloy |
Innovation Grants |
2010 |
Ohio |
A novel compound for treatment of T cell leukemia |
Huntsman Cancer Institute / Nikolaus Trede |
Innovation Grants |
2010 |
Utah |
Elucidating the Initiation Mechanism of the Fanconi Anemia Pathway of DNA Damage Repair |
Yale School of Medicine / Yong Xiong |
Innovation Grants |
2010 |
Connecticut |
In-UTR Mutations in Neuroblastoma: Functional Consequences and Therapeutic Implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko |
Innovation Grants |
2010 |
Pennsylvania |
Identification of New Therapeutic Targets in Pediatric Acute Lymphoblastic Leukemia Through Mosaic Trisomy and Aneuploidy-Based Synthetic Lethality Screens |
Dana-Farber Cancer Institute / David Pellman |
Innovation Grants |
2010 |
Massachusetts |
Pathogenesis of T-cell Acute Lymphoblastic Leukemia from Myeloproliferative Disorder |
Duke University / Motonari Kondo |
Innovation Grants |
2010 |
North Carolina |
Targeting Neovascularization in Graft-Versus-Host Disease |
Memorial Sloan-Kettering Cancer Center / Marcel van den Brink |
Innovation Grants |
2010 |
New York |
Identification of the Molecular Targets of MLL Translocation-Based Childhood Leukemia |
Stowers Institute for Medical Research / Ali Shilatifard |
Innovation Grants |
2010 |
Missouri |
Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia |
Nemours Center for Childhood Cancer Research / Andrew Napper |
Innovation Grants |
2010 |
Delaware |